NeuroMetrix Company Profile (NASDAQ:NURO)

About NeuroMetrix

NeuroMetrix logoNeuroMetrix, Inc. (NeuroMetrix) is a health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians manage chronic pain, nerve diseases and sleep disorders. The Company operates through the sale of medical equipment and consumables segment. Its products are sold in the United States and selected overseas markets. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The Company's products consist of a medical device used in conjunction with a consumable electrode or biosensor. Its products include Quell, which is a wearable device for relief of chronic intractable pain; SENSUS, which is a prescription neuro-stimulation device; DPNCheck, which is a nerve conduction test that is used to evaluate systemic neuropathies, and ADVANCE System, which is a platform for the performance of nerve conduction studies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NURO
  • CUSIP:
Key Metrics:
  • Previous Close: $1.43
  • 50 Day Moving Average: $1.59
  • 200 Day Moving Average: $1.68
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.61
  • P/E Growth: -0.01
  • Market Cap: $7.32M
  • Outstanding Shares: 5,118,000
  • Beta: 0.61
Additional Links:
Companies Related to NeuroMetrix:

Analyst Ratings

Consensus Ratings for NeuroMetrix (NASDAQ:NURO) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.25 (337.06% upside)

Analysts' Ratings History for NeuroMetrix (NASDAQ:NURO)
DateFirmActionRatingPrice TargetDetails
7/22/2016Rodman & RenshawReiterated RatingBuyView Rating Details
2/29/2016Dawson JamesReiterated RatingBuyView Rating Details
9/11/2015Maxim GroupInitiated CoverageBuy$8.00View Rating Details
(Data available from 8/26/2014 forward)


Earnings History for NeuroMetrix (NASDAQ:NURO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/21/2016Q216($0.93)($5.37)$1.22 million$2.65 millionViewListenView Earnings Details
4/21/2016Q116($0.95)($1.00)$2.65 million$2.28 millionViewListenView Earnings Details
10/22/2015Q315($0.08)($0.26)$6.47 million$2.10 millionViewListenView Earnings Details
7/22/2015Q215($0.48)$9.80 million$1.22 millionViewListenView Earnings Details
4/21/2015Q115($0.25)$1.33 million$1.28 millionViewListenView Earnings Details
2/12/2015Q414($0.36)$4.62 million$1.41 millionViewN/AView Earnings Details
10/28/2014Q314($0.19)$1.31 million$1.43 millionViewN/AView Earnings Details
7/24/2014Q413($0.85)$1.16 million$1.34 millionViewN/AView Earnings Details
2/13/2014($0.87)ViewListenView Earnings Details
10/23/2013Q313($0.26)$1.77 million$1.31 millionViewListenView Earnings Details
7/25/2013Q2 2013($0.92)$2.20 million$1.20 millionViewN/AView Earnings Details
2/3/2011($0.17)($0.18)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for NeuroMetrix (NASDAQ:NURO)
Current Year EPS Consensus Estimate: $-6.65 EPS
Next Year EPS Consensus Estimate: $-0.89 EPS


Dividend History for NeuroMetrix (NASDAQ:NURO)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for NeuroMetrix (NASDAQ:NURO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/18/2016Shai GozaniCEOBuy5,000$1.49$7,450.00View SEC Filing  
8/12/2016Thomas T HigginsInsiderBuy2,000$1.45$2,900.00View SEC Filing  
6/1/2016Shai GozaniCEOBuy2,500$1.71$4,275.00View SEC Filing  
5/23/2016Francis X McgillinVPBuy1,000$1.65$1,650.00View SEC Filing  
5/19/2016Shai GozaniCEOBuy12,000$1.55$18,600.00View SEC Filing  
5/19/2016Thomas T HigginsCFOBuy3,200$1.54$4,928.00View SEC Filing  
8/28/2015Thomas T HigginsCFOBuy4,500$0.92$4,140.00View SEC Filing  
8/20/2015Thomas T HigginsCFOBuy5,500$0.91$5,005.00View SEC Filing  
8/11/2015Shai GozaniCEOBuy16,300$0.91$14,833.00View SEC Filing  
11/9/2012Shai GozaniCEOBuy26,800$0.55$14,740.00View SEC Filing  
8/27/2012Krishnamurthy BalachandranCOOBuy5,000$0.67$3,350.00View SEC Filing  
8/21/2012Thomas T HigginsCFOBuy5,000$0.64$3,200.00View SEC Filing  
8/13/2012Krishnamurthy BalachandranCOOBuy5,000$0.70$3,500.00View SEC Filing  
8/8/2012Thomas T HigginsCFOBuy5,000$0.70$3,500.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for NeuroMetrix (NASDAQ:NURO)
DateHeadline logoNeuroMetrix Announces That Quell Will Be Featured in the Target Open House (NASDAQ:NURO) - August 25 at 11:39 AM logoNeuroMetrix Celebrates 10,000 Quell Facebook Fans with Pain Awareness Month Contest (NASDAQ:NURO) - August 22 at 6:31 PM logoNeuroMetrix Commentary on Strategic and Business Partnerships for Quell Wearable Pain Relief Technology (NASDAQ:NURO) - August 16 at 9:49 AM logoNeuroMetrix Inc. (NURO) (NASDAQ:NURO) - August 15 at 6:50 PM logoNeuroMetrix To Present Quell Wearable Pain Technology at National Association of Chain Drug Stores Total Store Expo (NASDAQ:NURO) - August 3 at 9:49 AM logoNeuroMetrix Reports that the Quell Health Cloud Has Collected Over 1 Million Hours of Quell Therapy and Health Data (NASDAQ:NURO) - August 2 at 11:26 AM logoNeuroMetrix Reports Recent Media Coverage for Quell (NASDAQ:NURO) - July 28 at 2:28 PM logoNEUROMETRIX, INC. Financials (NASDAQ:NURO) - July 27 at 1:04 PM
News IconChecking in on Stock Volatility for: NeuroMetrix Inc. (NASDAQ:NURO) - Engelwood Daily (NASDAQ:NURO) - July 22 at 6:24 PM
News IconRevenue Update on Neurometrix Inc(NASDAQ:NURO) - TheFounders Daily (NASDAQ:NURO) - July 22 at 6:24 PM logoNeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q2, 2016 By the Numbers : July 22, 2016 (NASDAQ:NURO) - July 22 at 12:31 PM logoEdited Transcript of NURO earnings conference call or presentation 21-Jul-16 12:00pm GMT (NASDAQ:NURO) - July 21 at 7:22 PM
News IconNeuroMetrix Reports Q2 2016 Financial Results and Highlights (NASDAQ:NURO) - July 21 at 6:51 PM
News IconInsiders Increasing Positions in: NeuroMetrix Inc. (NASDAQ:NURO) - Press Telegraph (NASDAQ:NURO) - July 21 at 9:27 AM
News IconNeuroMetrix Quell Device Makes Second Appearance at the American Podiatric Medical Association Annual Scientific Meeting (NASDAQ:NURO) - July 14 at 10:07 AM logoNeuroMetrix, Inc. Announces Date for 2016 Second Quarter Financial Results Conference Call (NASDAQ:NURO) - July 14 at 7:18 AM logoNeuroMetrix Expands DPNCheck Commercialization in Mexico (NASDAQ:NURO) - July 13 at 7:13 AM logoNeuroMetrix' Quell Device Makes Second Appearance at the American Podiatric Medical Association Annual Scientific Meeting (NASDAQ:NURO) - July 12 at 11:13 AM logoNeuroMetrix’ Quell Device Makes Second Appearance at the American Podiatric Medical Association Annual Scientific Meeting (NASDAQ:NURO) - July 12 at 11:00 AM logoNeuroMetrix Announces Launch of Quell Sport Electrode (NASDAQ:NURO) - July 7 at 7:21 AM logoNeuroMetrix Reports Peer-Reviewed Publication of Initial Quell Study (NASDAQ:NURO) - July 6 at 7:21 AM logoNeuroMetrix (NYSE:NURO) target price increased to $5 as covered today by Rodman & Renshaw (NASDAQ:NURO) - July 4 at 11:13 AM logoNeuroMetrix (NURO), WBC Group Enter Quell Distribution Agreement (NASDAQ:NURO) - June 30 at 9:26 AM logoNeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 (NASDAQ:NURO) - June 28 at 1:28 PM logoNeuroMetrix Announces Quell Distribution Agreement with WBC Group (NASDAQ:NURO) - June 28 at 11:31 AM logoCoverage initiated on NeuroMetrix by Rodman & Renshaw (NASDAQ:NURO) - June 28 at 7:05 AM logoNeuroMetrix (NURO) Announces Submission of CE Application for Quell (NASDAQ:NURO) - June 22 at 11:15 AM logoNeuroMetrix Submits CE Mark Application for Quell Wearable Pain Relief Device (NASDAQ:NURO) - June 22 at 7:29 AM logoNeuroMetrix Showcases Quell Technology at the Western Foot & Ankle Conference (NASDAQ:NURO) - June 21 at 7:19 AM logoNeuroMetrix (NURO) Says Quell Tech Now Available via (NASDAQ:NURO) - June 14 at 6:18 PM logoNeuroMetrix Announces Quell Distribution in Canada (NASDAQ:NURO) - June 14 at 2:49 PM logoNeuroMetrix Reports Executive Stock Transactions during May 2016 (NASDAQ:NURO) - June 10 at 11:49 AM logoNeuroMetrix Showcases Quell Technology at SLEEP 2016, the 30th Anniversary Meeting of the Associated Professional Sleep Societies (NASDAQ:NURO) - June 9 at 7:09 AM logoNeuroMetrix Closes $21.3 Million At-The-Market Private Placement of Preferred Stock and Warrants and Redeems $13.8 Million of Outstanding Preferred Stock (NASDAQ:NURO) - June 8 at 4:48 PM logoNeuroMetrix Celebrates 20 Year Anniversary (NASDAQ:NURO) - June 6 at 7:18 AM logoNEUROMETRIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securit (NASDAQ:NURO) - June 3 at 4:12 PM logoNeuroMetrix Announces $21.3 Million at the Market Private Placement of Preferred Stock and Warrants (NASDAQ:NURO) - June 2 at 4:45 PM logo4:20 pm NeuroMetrix enters into securities purchase agreement with an institutional investor in connection with a 21,300 share private placement of series C convertible preferred stock at $1,000/share for gross proceeds of $21.3 mln (NASDAQ:NURO) - June 2 at 4:20 PM logoNeuroMetrix Announces Availability of Quell in Approximately 1,000 Chain Drug Stores (NASDAQ:NURO) - June 2 at 7:25 AM logoNeuroMetrix to Present at the LD Micro Invitational Conference on June 7, 2016 (NASDAQ:NURO) - May 31 at 11:00 AM logoAnalysts Set 1-Year Price Target Of $3 On NeuroMetrix, Inc. (NASDAQ:NURO) Stock - (NASDAQ:NURO) - May 29 at 12:24 PM logoNeuroMetrix Reports the Launch of the Quell® Health Cloud for Android - Business Wire (press release) (NASDAQ:NURO) - May 27 at 12:41 PM logoNeuroMetrix, Inc. (NASDAQ:NURO) Impact Score At 0 - Investor Newswire (NASDAQ:NURO) - May 27 at 12:41 PM
News IconNeuroMetrix launches the Quell Health Cloud for Android (NASDAQ:NURO) - May 27 at 12:41 PM logoNeuroMetrix Reports the Launch of the Quell® Health Cloud for Android (NASDAQ:NURO) - May 26 at 7:07 AM
News IconFrancis Mcgillin, an Insider in Neurometrix Inc (NASDAQ:NURO), Paid for 1000 shares of the Company - Wall Street Hints and News (NASDAQ:NURO) - May 24 at 12:53 PM logoNeuroMetrix Officer Acquires –—,……… Shares (NASDAQ:NURO) - May 23 at 6:54 PM
News IconWhat after Thomas Higgins's Insider Acquisition of Neurometrix Inc (NASDAQ:NURO) Stock? - Wall Street Hints and News (NASDAQ:NURO) - May 20 at 12:38 PM logoAlpha One Assigns Impact Score Of 0 To NeuroMetrix, Inc. (NASDAQ:NURO) - Investor Newswire (NASDAQ:NURO) - May 18 at 1:02 PM logoNeuroMetrix Announces Frank McGillin, SVP and General Manager, Consumer to participate in a Digital Health Summer Summit Panel at BIO 2016 (NASDAQ:NURO) - May 18 at 7:42 AM


NeuroMetrix (NASDAQ:NURO) Chart for Friday, August, 26, 2016

Last Updated on 8/26/2016 by Staff